PMFA
GSK icon

Plante Moran Financial Advisors’s GSK GSK Stock Holding History

Plante Moran Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.77K Buy
+91
New +$4.81K ﹤0.01% 650
2025
Q4 		– Sell
-240
Closed -$10.4K – 849
2025
Q3 		$10.4K Hold
240
– – ﹤0.01% 545
2025
Q2 		$9.22K Hold
240
– – ﹤0.01% 573
2025
Q1 		$9.3K Hold
240
– – ﹤0.01% 580
2024
Q4 		$8.12K Sell
240
-648
-73% -$23.3K ﹤0.01% 608
2024
Q3 		$36.3K Buy
888
+240
+37% +$9.82K ﹤0.01% 429
2024
Q2 		$24.9K Sell
648
-59
-8% -$2.48K ﹤0.01% 444
2024
Q1 		$30.3K Hold
707
– – ﹤0.01% 435
2023
Q4 		$26.2K Hold
707
– – ﹤0.01% 410
2023
Q3 		$25.6K Hold
707
– – ﹤0.01% 385
2023
Q2 		$25.2K Hold
707
– – ﹤0.01% 399
2023
Q1 		$25.2K Hold
707
– – ﹤0.01% 406
2022
Q4 		$24.8K Hold
707
– – ﹤0.01% 426
2022
Q3 		$21K Sell
707
-1
-0.1% -$38 ﹤0.01% 452
2022
Q2 		$39K Sell
708
-135
-16% -$7.45K 0.01% 346
2022
Q1 		$46K Buy
843
+195
+30% +$10.6K 0.01% 349
2021
Q4 		$36K Sell
648
-240
-27% -$12.5K 0.01% 423
2021
Q3 		$42K Buy
888
+328
+59% +$16.5K 0.01% 414
2021
Q2 		$28K Hold
560
– – 0.01% 489
2021
Q1 		$25K Hold
560
– – 0.01% 502
2020
Q4 		$26K Hold
560
– – 0.01% 472
2020
Q3 		$26K Hold
560
– – 0.01% 440
2020
Q2 		$29K Sell
560
-80
-13% -$4.1K 0.01% 370
2020
Q1 		$30K Buy
640
+80
+14% +$4.27K 0.01% 329
2019
Q4 		$33K Sell
560
-165
-23% -$9.18K 0.01% 385
2019
Q3 		$39K Hold
725
– – 0.01% 379
2019
Q2 		$36K Sell
725
-43
-6% -$2.16K 0.01% 391
2019
Q1 		$40K Sell
768
-6
-0.8% -$300 0.01% 377
2018
Q4 		$37K Buy
774
+4
+0.5% +$197 0.01% 345
2018
Q3 		$39K Buy
770
+210
+38% +$10.7K 0.01% 346
2018
Q2 		$28K Hold
560
– – 0.01% 431
2018
Q1 		$27K Hold
560
– – 0.01% 451
2017
Q4 		$25K Hold
560
– – 0.01% 466
2017
Q3 		$28K Hold
560
– – 0.02% 415
2017
Q2 		$30K Sell
560
-113
-17% -$6.02K 0.02% 405
2017
Q1 		$35K Buy
673
+41
+6% +$2.08K 0.02% 373
2016
Q4 		$30K Hold
632
– – 0.02% 413
2016
Q3 		$34K Sell
632
-765
-55% -$41.9K 0.02% 391
2016
Q2 		$76K Buy
1,397
+37
+3% +$1.95K 0.06% 229
2016
Q1 		$69K Sell
1,360
-686
-34% -$34.2K 0.05% 219
2015
Q4 		$103K Buy
2,046
+686
+50% +$35K 0.08% 181
2015
Q3 		$65K Buy
1,360
+800
+143% +$41.6K 0.05% 231
2015
Q2 		$29K Hold
560
– – 0.02% 374
2015
Q1 		$32K Sell
560
-42
-7% -$2.41K 0.02% 344
2014
Q4 		$32K Sell
602
-894
-60% -$50K 0.02% 341
2014
Q3 		$86K Hold
1,496
– – 0.08% 183
2014
Q2 		$100K Buy
1,496
+936
+167% +$63.4K 0.09% 152
2014
Q1 		$37K Sell
560
-202
-27% -$13.7K 0.04% 194
2013
Q4 		$51K Sell
762
-955
-56% -$61.9K 0.03% 230
2013
Q3 		$108K Buy
1,717
+1,076
+168% +$69.3K 0.07% 107
2013
Q2 		$40K Buy
+641
New +$40.7K 0.03% 184

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Plante Moran Financial Advisors's GSK Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in GSK (GSK) in Q2 2026: 91 shares worth $4.77K. The stake represents ﹤0.01% of the portfolio and ranks #650 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in GSK as recently as Q3 2025.

Plante Moran Financial Advisors first reported a position in GSK in Q2 2013 and has held it in 51 quarters since. The position peaked at $108K in Q3 2013. 627 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Plante Moran Financial Advisors held 91 shares of GSK worth $4.77K as of Q2 2026.
  • GSK was a new Plante Moran Financial Advisors position in Q2 2026.
  • GSK made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #650 holding.
  • Plante Moran Financial Advisors first reported a position in GSK in Q2 2013 and has held it in 51 quarters since.
  • Plante Moran Financial Advisors's GSK position peaked at $108K in Q3 2013.
  • 627 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.